Combination of voriconazole and an antifungal CYP2C19 inhibitor

Details for Australian Patent Application No. 2005219017 (hide)

Owner Pfizer Inc.

Inventors Humphrey, Michael John

Agent Spruson & Ferguson

Pub. Number AU-B-2005219017

PCT Pub. Number WO2005/084671

Priority 60/545,663 17.02.04 US; 0402491.5 04.02.04 GB

Filing date 13 January 2005

Wipo publication date 15 September 2005

Acceptance publication date 24 July 2008

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/084671 Priority application(s): WO2005/084671

24 July 2008 Application Accepted

  Published as AU-B-2005219017

20 November 2008 Standard Patent Sealed

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219032-Composition for regulating the trophism of hair follicles and the cutaneous production of sebum and use thereof in androgenetic alopecia

2005219003-Emanator device